Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for OZURDEX
- Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery
- Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema
- Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma
- Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)
- Dexamethasone (0.4mg) Ophthalmic Insert.
- Ozurdex Monotherapy Trial
- A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina
- Ozurdex in Suboptimal Diabetic Macular Edema Patients
- Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
- Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO
- Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
- Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema
- Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema
- INCB053914 and Pomalidomide With Dexamethasone for Relapsed and/or Refractory Multiple Myeloma
- Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema (LOADEX)
- Dexamethasone Implant for Retinal Detachment in Uveal Melanoma
- Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
- Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
- Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM
- The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial (COED Trial)
- A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated
- Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China
- Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
- Regional Anesthesia to Reduce Opioid Use Following FESS
- Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema
- Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
- Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma
- The Effects of Intravitreal Ozurdex Implant in DME
- Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME
- Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis
- Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane
- Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
- Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study
- Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study
- Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases
- Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema
- Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema
- Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
- Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema
- Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema
- Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma
- Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema
- PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
- A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)
- An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
- Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.
- A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
- Study of the Effectiveness of Ozurdex for the Control of Uveitis
- Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
- Safety and Efficacy of Dexamethasone (OZURDEX®) Intravitreal Implant in Korea
- Diabetic Macular Edema Treated With Ozurdex (DMEO)
- Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
- Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome
- Phase II Combination Steroid and Anti-VEGF for Persistent DME
- A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion
- TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
- Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion
- A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema
- Ozurdex for Retinal Vein Occlusion Study (ORVO Study)
- Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery
- Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
- The Effect of Intravitreal Ozurdex on DME After Cataract Surgery
- A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes
- Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema
- Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema
- A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
- Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
- Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)
- Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion
- Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
- A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
- Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
- Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion
- Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema
- A Long-Term Safety Study of OZURDEX® in Clinical Practice
- Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
- Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
- Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.
- A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)
- Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
- Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
- Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
- Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
- Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema
- Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
- Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion
- Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery
- Ozurdex for Macular Edema Post Membrane Peeling
- OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab
- Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
- Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration
- Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)
- R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma
Clinical trials list
click for details